MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis

Gynecologic Oncology

Volumn 121, Issue 3, 2011, Pages 434-443

  Thériault, Catherine ^a   Pinard, Maxime ^a   Comamala, Marina ^a   Migneault, Martine ^a   Beaudin, Julie ^a   Matte, Isabelle ^a   Boivin, Marianne ^a   Piché, Alain ^a   Rancourt, Claudine ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

CA125; Invasion; MUC16; Mucins; Ovarian cancer; Tumorigenesis

Indexed keywords

CA 125 ANTIGEN; MUC16 PROTEIN; MUCIN; NERVE CELL ADHESION MOLECULE; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CELL MOTILITY; CELL SURFACE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; EPITHELIAL OVARIAN CANCER; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; OVARY CARCINOGENESIS; OVARY METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; CA-125 ANTIGEN; CADHERINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE PROTEINS; MICE; MICE, NUDE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; VIMENTIN;

EID: 79957525887     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.02.020     Document Type: Article

References (51)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 49 2009 71 96
2. E.E. Partridge, and M.N. Barnes Epithelial ovarian cancer: prevention, diagnosis, and treatment CA Cancer J Clin 49 1999 297 320
3. R.F. Ozols, M.A. Bookman, and D.C. Connolly Focus on epithelial ovarian cancer Cancer Cell 5 2004 19 24 (Pubitemid 38121593)
4. R.C. Bast Jr., T.L. Klug, and E. St-John A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer N Eng J Med 309 1983 883 887 (Pubitemid 13014028)
5. P.A. Canney, M. Moore, P.M. Wilkinson, and R.D. James Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker Br J Cancer 50 1984 765 769 (Pubitemid 15221441)
6. I.B. Vergote, O.P. Bormer, and V.M. Abeler Evaluation of serum CA 125 levels in the monitoring of ovarian cancer Am J Obstet Gynecol 157 1987 88 92 (Pubitemid 17099890)
7. S.E. Kabawat, R.C. Bast Jr., and W.R. Welch Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types Am J Clin Pathol 79 1983 98 104 (Pubitemid 13222196)
8. E.V. Hogdall, L. Christensen, and S.K. Kjaer CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From the Danish "MALOVA" Ovarian Cancer Study Gynecol Oncol 104 2007 508 515
9. R. Gaetje, D.W. Winnekendonk, A. Scharl, and M. Kaufmann Ovarian cancer antigen CA125 enhances the invasiveness of the endometriotic cell line EEC 145 J Soc Gynecol Investig 6 1999 278 281 (Pubitemid 29494936)
10. A. Rump, Y. Morikawa, and M. Tanaka Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion J Biol Chem 279 2004 9190 9198 (Pubitemid 38295982)
11. M.S. Patankar, Y. Jing, and J.C. Morrison Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125 Gynecol Oncol 99 2005 704 713 (Pubitemid 41686556)
12. M. Boivin, D. Lane, A. Piché, and C. Rancourt CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis Gynecol Oncol 115 2009 407 413
13. H.M. Davis, V.R. Zurawski, R.C. Bast Jr., and T.L. Klug Characterization of the CA125 antigen associated with human epithelial ovarian carcinomas Cancer Res 46 1986 6143 6148 (Pubitemid 17221746)
14. de los Frailes MT, S. Stark, W. Jaeger, A. Hoerauf, and L. Wildt Purification and characterization of the CA125 tumor-associated antigen from human ascites Tumor Biol 14 1993 18 29 (Pubitemid 23192947)
15. H. Kobayashi, W. Ida, T. Terao, and Y. Kawashima Molecular characteristics of the CA125 antigen produced by human endometrial epithelial cells: comparison between eutopic and heterotopic epithelial cells Am J Obstet Gynecol 169 1993 725 730 (Pubitemid 23290200)
16. J.L. Fendrick, K.A. Staley, M.K. Gee, S.R. McDougald, J.G. Quirk Jr., and T.J. O'Brien Characterization of CA125 synthesized by the human epithelial amnion WISH cell line Tumor Biol 14 1993 310 318 (Pubitemid 23357720)
17. A. Nagata, N. Hirota, T. Sakai, M. Fujimoto, and T. Komoda Molecular nature and possible presence of a membranous glycan-phosphatidylinositol anchor of CA125 antigen Tumor Biol 12 1991 279 286
18. B.W. Yin, and K.O. Lloyd Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin (Muc16) J Biol Chem 276 2001 27371 27375
19. B.W. Yin, A. Dnistrian, and K.O. Lloyd Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene Int J Cancer 98 2002 737 740 (Pubitemid 34225625)
20. N. Kui Wong, and R.L. Easton Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125 J Biol Chem 278 2003 28619 286334
21. T.J. O'Brien, J.B. Beard, and L.J. Underwood The CA125 gene: an extracellular superstructure dominated by repeated sequences Tumour Biol 22 2001 348 366 (Pubitemid 34062947)
22. T.J. O'Brien, J.B. Beard, L.J. Underwood, and K. Shigemasa The CA125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure Tumour Biol 23 2002 154 169 (Pubitemid 44858307)
23. S.J. Gendler, and A.P. Spicer Epithelial mucin genes Annu Rev Physiol 57 1995 607 634
24. S. Satoh, Y. Hinoda, and T. Hayashi Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule Int J Cancer 88 2000 507 518
25. A.P. Singh, N. Moniaux, S.C. Chauhan, J.L. Meza, and S.K. Batra Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis Cancer Res 64 2004 622 630 (Pubitemid 38120902)
26. M. Komatsu, S. Jepson, and M.E. Arango Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor Oncogene 20 2001 461 470 (Pubitemid 32158226)
27. J. Wesseling, S.W. van der Valk, and H.L. Vos Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components J Cell Biol 129 1995 255 265
28. D. Vergara, B. Merlot, and J.P. Lucot Epithelial-mesenchymal transition in ovarian cancer Cancer Lett 291 2010 59 66
29. H. Hugo, M.L. Ackland, and T. Blick Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression J Cell Physiol 213 2007 374 383 (Pubitemid 47509716)
30. D.C. Radisky Epithelial-mesenchymal transition J Cell Sci 118 2005 4325 4326
31. J.P. Thiery Epithelial-mesenchymal transitions in tumor progression Nat Rev Cancer 2 2002 442 454
32. M.A. Huber, N. Kraut, and H. Beug Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr Opin Cell Biol 17 2005 548 558 (Pubitemid 41267170)
33. U. Cavallaro, and G. Christofori Cell adhesion and signaling by cadherins and Ig-CAMs in cancer Nat Rev Cancer 4 2004 118 132 (Pubitemid 38198740)
34. S.A. Gayther, K.L. Gorringe, and S.J. Ramus Identification of germ-line E-cadherin mutations in gastric cancer families of European origin Cancer Res 58 1998 4086 4089 (Pubitemid 28440561)
35. P. Guilford, J. Hopkins, J. Harraway, M. McLeod, N. McLeod, and P. Harawira E-cadherin germline mutations in familial gastric cancer Nature 392 1998 402 405 (Pubitemid 28168738)
36. M.L. Hermiston, and J.I. Gordon Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin Science 270 1995 1203 1207
37. C.Y. Sasaki, H. Lin, P.J. Morin, and D.L. Longo Truncation of the extracellular region abrogates cell contact but retains the growth-suppressive activity of E-cadherin Cancer Res 60 2000 7057 7065 (Pubitemid 32059185)
38. K. Sawada, A.K. Mitra, and A.R. Radjabi Loss of E-cadherin promotes ovarian cancer metastasis via α5-integrin, which is a therapeutic target Cancer Res 68 2008 2329 2339 (Pubitemid 351521807)
39. M.T. Nieman, R.S. Prudoff, K.R. Johnson, and M.J. Wheelock N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression J Cell Biol 147 1999 631 644
40. K.O. Lloyd, B.W.T. Yin, and V. Kudryashov Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule Int J Cancer 71 1997 842 850 (Pubitemid 27237208)
41. A. Piché, J. Grim, and C. Rancourt Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7 Cancer Res 58 1998 2134 2140 (Pubitemid 28232899)
42. K. Kasono, Y. Heike, and J. Xiang Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562 Cancer Gene Ther 7 2000 151 159 (Pubitemid 30080999)
43. A.L. Veatch, L.F. Carson, and S. Ramakrishnan Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells Int J Cancer 58 1994 393 399 (Pubitemid 24254650)
44. E. Darai, J.Y. Scoazec, and F. Walker-Combrouze Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases Hum Pathol 28 1997 922 928 (Pubitemid 27355552)
45. M.P. Ponnusamy, I. Lakshmanan, and M. Jain MUC-4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells Oncogene 2010 10.1038/onc.2010.309
46. M. Miyaki, K. Tanaka, R. Kikuchi-Yanoshita, M. Muraoka, M. Konishi, and M. Takeichi Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells Oncogene 11 1995 2547 2552 (Pubitemid 26023822)
47. kip1 J Cell Biol 142 1998 557 571 (Pubitemid 28361560)
48. K.G. Kohlgraf, A.J. Grawron, and M. Higashi Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line Cancer Res 63 2003 5011 5020 (Pubitemid 37022639)
49. J.A. Schroeder, M.C. Adriance, M.C. Thompson, T.D. Camenisch, and S.J. Gendler MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion Oncogene 22 2003 1324 1332 (Pubitemid 36384593)
50. J.A. Schroeder, M.C. Thompson, M.M. Gardner, and S.J. Gendler Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland J Biol Chem 276 2001 13057 13064
51. I. Konishi, J.L. Fendrick, T.H. Parmley, J.G. Quirk Jr., and T.J. O'Brien Epidermal growth factor enhances secretion of the ovarian tumor-associated cancer antigen CA125 from the human amnion WISH cell line J Soc Gyn Invest 1 1994 89 96 (Pubitemid 2064224)